Covid 19 Timeline of Events in Andover: Difference between revisions

From Andover Answers
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
'''
'''
JULY 2020'''
JULY 2020'''
'''Pfizer Inc.'s Andover facility played a critical role in the development of the first mRNA vaccines in 2020.'''<br>  In July 2020, Pfizer's Andover facility began mass manufacturing the RNA required for the mRNA vaccine it co-developed with the German pharmaceutical firm, BioNTech.  Sold under the brand name Comirnity, [https://en.wikipedia.org/wiki/Pfizer%E2%80%93BioNTech_COVID-19_vaccine the Pfizer BioNTech Covid-19 vaccine] production and trials were sped up and scaled up to meet the need for 50 million doses by the end of 2021. <ref> Andover's Piece of the Vaccine, ''The Eagle Tribune'', December 20, 2020. </ref>
'''Pfizer Inc.'s Andover facility played a critical role in the development of the first mRNA vaccines in 2020.'''<br>  In July 2020, Pfizer's Andover facility began mass manufacturing the RNA required for the mRNA vaccine it co-developed with the German pharmaceutical firm, BioNTech.  Sold under the brand name Comirnity, [https://en.wikipedia.org/wiki/Pfizer%E2%80%93BioNTech_COVID-19_vaccine the Pfizer BioNTech Covid-19 vaccine] production and trials were sped up and scaled up to meet the urgent demands of a private-public partnership initiated by the US government which enabled special fast-tracked government approval of vaccines under trail. <ref> Andover's Piece of the Vaccine, ''The Eagle Tribune'', December 20, 2020. </ref>

Revision as of 17:35, 24 January 2024

JULY 2020 Pfizer Inc.'s Andover facility played a critical role in the development of the first mRNA vaccines in 2020.
In July 2020, Pfizer's Andover facility began mass manufacturing the RNA required for the mRNA vaccine it co-developed with the German pharmaceutical firm, BioNTech. Sold under the brand name Comirnity, the Pfizer BioNTech Covid-19 vaccine production and trials were sped up and scaled up to meet the urgent demands of a private-public partnership initiated by the US government which enabled special fast-tracked government approval of vaccines under trail. [1]

  1. Andover's Piece of the Vaccine, The Eagle Tribune, December 20, 2020.